Copyright
©The Author(s) 2023.
World J Cardiol. Mar 26, 2023; 15(3): 84-94
Published online Mar 26, 2023. doi: 10.4330/wjc.v15.i3.84
Published online Mar 26, 2023. doi: 10.4330/wjc.v15.i3.84
Procedural characteristics (n = 500) | |
Lesion details | |
Total number of lesions treated with FlexyRap® (n) | 730 |
Total number of stents deployed (n) | 730 |
Total stent per lesion (n = 500 patients) (Total no. stent deployed (730)/Total lesion locations (729) | 1.001 |
Total lesion per vessel (n = 500 patients); Total lesion locations (729)/(Sum of total No of diseased vessel (731) | 0.997 |
Lesion locations (729) n (%) | |
D1 | 6 (0.82) |
Distal LAD | 17 (2.33) |
Distal LCx | 4 (0.54) |
Distal RCA | 16 (2.19) |
LAD | 279 (38.27) |
LCx | 98 (13.44) |
LM | 1 (0.13) |
MID LAD | 19 (2.6) |
MID LCx | 9 (1.23) |
MID RCA | 15 (2.05) |
O Mid | 7 (0.96) |
OM | 4 (0.54) |
OM1 | 8 (1.09) |
OM2 | 6 (0.82) |
OM3 | 1 (0.13) |
OMI | 1 (0.13) |
Osteoproximal LAD | 2 (0.27) |
Osteoproximal RCA | 4 (0.54) |
PDA | 7 (0.96) |
PLV | 3 (0.41) |
Proximal LAD | 23 (3.15) |
Proximal RCA | 15 (2.05) |
Proximal LCx | 7 (0.96) |
PTCA | 8 (1.09) |
Ramus intermedius | 8 (1.09) |
RCA | 156 (21.40) |
RCX | 2 (0.27) |
PLB | 2 (0.27) |
POM | 1 (0.13) |
Stent length (mean ± SD) | 26.03 ± 10.86 |
Stent diameter (mean ± SD) | 3.06 ± 0.41 |
Type of stenosis, n (%) | |
de novo | 500 (100) |
Thrombus load (n = 731), n (%) | |
None | 519 (71) |
Mild | 90 (12.31) |
Moderate | 59 (8.07) |
Severe | 63 (8.62) |
Lesion type [ACC/AHA classification] (n = 731), n (%) | |
Type A | 20 (2.73) |
Type B1 | 193 (26.40) |
Type B2 | 302 (41.31) |
Type C | 216 (29.55) |
Stent balloon inflation pressure (atm) (mean ± SD) (n = 500) | 12.52 ± 1.75 |
TIMI FLOW n (%) | |
II | 9 (1.8) |
III | 491 (98.2) |
% of occlusion (mean ± SD) (n = 500) | 88.60 ± 8.79 |
All values are presented in n (%) or mean ± SD |
- Citation: Garg N, Chawla R, Tandon V, Garg D, Parshottam N, Vani P, Neuss M. Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease. World J Cardiol 2023; 15(3): 84-94
- URL: https://www.wjgnet.com/1949-8462/full/v15/i3/84.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i3.84